What Moral Virtues Should We Enhance?
Yesterday evening in front of a record audience in the OxfordMartinSchoolbuilding, Dr. Molly Crockett delivered the Wellcome Lecture in Neuroethics: “Moral enhancement? Evidence and challenges” (a podcast of the lecture will soon appear in the events archives here)
In her engaging talk, Dr Crockett spoke of the emerging body of neuroscience research she and others have been conducting on neurobiological modifiers of moral behavior and how manipulations in neurotransmitter systems can affect that moral behavior.
For example, in a study where subjects were presented with two classic trolley problems, whether they had previously received an antidepressant that increased the availability of the neurotransmitter, serotonin, in the neuronal synapse (in this case, a Selective Serotonin Reuptake Inhibitor – SSRI) significantly shifted peoples decisions into a deontological, as opposed to consequentialist framework. Namely, the group that had received the SSRI was less likely to say it was ok to push a very large man off of a bridge in front of a trolley in order to save five workers who would certainly otherwise die.
From a deontological point of view, this increased aversion to harming others after taking the SSRI might be thought of as a moral enhancement, but might be thought of as impairment to a consequentialist.